Moloney murine leukemia virus activates NF-kappa B

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• Nonacutely transforming retroviruses like M-MuLV induce tumors through mechanisms distinct from oncogene transduction.
• While promoter insertion and enhancer activation are known mechanisms, some M-MuLV-induced tumors lack site-specific proviral insertions, suggesting other pathways.
• The precise molecular mechanisms by which leukemia viruses drive tumorigenesis remain incompletely understood.

Purpose of the Study:

• To investigate the molecular mechanisms underlying M-MuLV-induced tumorigenesis.
• To determine if M-MuLV infection impacts the activity of Rel family transcription factors.
• To identify the specific subunits involved in virus-induced transcription factor complexes.

Main Methods:

• Gel shift analyses using kappaB DNA-binding motifs from the murine immunoglobulin kappa light chain enhancer.
• Supershifting and immunoblotting to identify protein subunits within the transcription factor complexes.
• Transient transfections with kappaB-dependent reporter plasmids to assess transcriptional activation.

Main Results:

• M-MuLV infection activated at least two distinct kappaB enhancer-binding complexes in murine cells.
• These complexes were composed of p50, p52, RelB, and c-Rel subunits.
• M-MuLV-infected cells exhibited transcriptional activation of kappaB-dependent reporter genes.

Conclusions:

• M-MuLV infection induces the expression and activity of Rel/NF-kappaB transcription factors.
• This virus-induced transcription factor activity represents a potential mechanism for M-MuLV-induced leukemia.
• These findings offer insight into virus-driven tumorigenesis beyond oncogene capture or direct proviral insertion.